PEOPLE - Changes at FlowMedica:
This article was originally published in Clinica
Executive Summary
FlowMedica (Fremont, California) has named Gordon Snyder vice-president of sales, as the company moves to commercialise its products. The firm develops intervascular systems to deliver therapeutic agents direct to the kidneys via the renal arteries (targeted renal therapy - TRT) to prevent and treat kidney dysfunction resulting from radiographic contrast media, administered during coronary intervention and diagnostic procedures. Prior to joining FlowMedica, Mr Snyder had managed sales at Novoste and Medtronic among other device companies.